Advanced search
Publication Cover
Journal of Medical Economics Volume 13, 2010 - Issue 2
Submit an article Journal homepage
1,342
Views
15
CrossRef citations to date
0
Altmetric
Original article

Cost effectiveness of memantine in Alzheimer's disease in the UK

B. Rive Université Claude Bernard Lyon 1, France; Lundbeck SAS, France
,
M. Grishchenko Lundbeck SAS, FranceCorrespondence[email protected]
, MSc,
C. Guilhaume–Goulant Lundbeck SAS, France
,
C. Katona Department of Mental Health Sciences, University College London, UK
,
G. Livingston Department of Mental Health Sciences, University College London, UK; Camden and Islington NHS Foundation Trust, UK
,
M. Lamure Université Claude Bernard Lyon 1, France
,
M. Toumi Université Claude Bernard Lyon 1, France
&
C. François Lundbeck SAS, France
 show all
Pages 371-380 | Published online: 26 May 2010

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Anees Shajhan Ebrahem & Mark Oremus. (2018) A pharmacoeconomic evaluation of cholinesterase inhibitors and memantine for the treatment of Alzheimer’s disease. Expert Opinion on Pharmacotherapy 19:11, pages 1245-1259.
Read now
Shanlian Hu, Xin Yu, Shengdi Chen, Emilie Clay, Mondher Toumi & Dominique Milea. (2015) Memantine for treatment of moderate or severe Alzheimer’s disease patients in urban China: clinical and economic outcomes from a health economic model. Expert Review of Pharmacoeconomics & Outcomes Research 15:4, pages 565-578.
Read now
Juanita Hoe, Claudia Cooper & Gill Livingston. (2013) An overview of the LASER-AD study: A longitudinal epidemiological study of people with Alzheimer's disease. International Review of Psychiatry 25:6, pages 659-672.
Read now
Nathan Herrmann, Abby Li & Krista Lanctôt. (2011) Memantine in dementia: a review of the current evidence. Expert Opinion on Pharmacotherapy 12:5, pages 787-800.
Read now

Articles from other publishers (11)

Pei-Jung Lin, Brittany D’Cruz, Ashley A. Leech, Peter J. Neumann, Myrlene Sanon Aigbogun, Dorothee Oberdhan & Tara A. Lavelle. (2019) Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer’s Disease Interventions. PharmacoEconomics 37:4, pages 597-608.
Crossref
Ione Ayala Gualandi de Oliveira, Rosângela Caetano, Ricardo Ewback Steffen & Aline Navega Biz. (2019) A systematic review of economic evaluations of the use of memantine alone or combined with donepezil for moderate to severe Alzheimer’s disease. Revista Brasileira de Geriatria e Gerontologia 22:4.
Crossref
Kim-Huong Nguyen, Tracy A. Comans & Colin Green. (2018) Where are we at with model-based economic evaluations of interventions for dementia? a systematic review and quality assessment. International Psychogeriatrics 30:11, pages 1593-1605.
Crossref
Feng Pan, Odette Reifsnider, Ying Zheng, Irina Proskorovsky, Tracy Li, Jianming He & Sonja V. Sorensen. (2018) Modeling Clinical Outcomes in Prostate Cancer: Application and Validation of the Discrete Event Simulation Approach. Value in Health 21:4, pages 416-422.
Crossref
Darshan Zala, Dennis Chan & Paul McCrone. (2018) The cost-effectiveness implications of suboptimal treatment for different severities of Alzheimer's disease in the UK. International Journal of Geriatric Psychiatry 33:2, pages 307-315.
Crossref
Luis Hernandez, Asli Ozen, Rodrigo DosSantos & Denis Getsios. (2016) Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer’s Disease. PharmacoEconomics 34:7, pages 681-707.
Crossref
Jonathan K.A. Mills, Jatinder S. Minhas & Samantha L. Robotham. (2014) An assessment of the dementia CQUIN – an audit of improving compliance. Dementia 13:5, pages 697-703.
Crossref
Premkumar Jeyapaul & Simon Manchip. (2014) Management guidelines for behavioural and psychotic symptoms in persons with dementia—A review article. Open Journal of Psychiatry 04:01, pages 5-8.
Crossref
Katherine A. Lyseng-Williamson & Kate McKeage. (2012) Once-Daily Memantine. Drugs & Aging 30:1, pages 51-58.
Crossref
Kelly M MakinoAnton P Porsteinsson. (2011) Memantine: a treatment for Alzheimer’s disease with a new formulation. Aging Health 7:3, pages 349-362.
Crossref
Jaclyn Cappell, Nathan Herrmann, Stephen Cornish & Krista L. Lanctôt. (2010) The Pharmacoeconomics of Cognitive Enhancers in Moderate to Severe Alzheimerʼs Disease. CNS Drugs 24:11, pages 909-927.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.